Plasma proteomic signatures of cerebrovascular disease

Abstract

Background: Cerebrovascular disease (CeVD) is a clinically significant disease entity, known to be associated with increased risk of cognitive decline [1]. However, the lack of validated blood biomarkers for CeVD, limits advances in detection and intervention.

The paper